Global Cognitive and Memory Enhancer Drugs Market Research Report 2020

Cognitive enhancers are drugs and supplements, which are majorly used to treat patients suffering from Alzheimer's disease, schizophrenia, stroke, attention deficit hyperactivity disorder, or aging.
In 2017, the global Cognitive and Memory Enhancer Drugs market size was 4130 million US$ and is forecast to 8030 million US in 2025, growing at a CAGR of 8.7% from 2018. The objectives of this study are to define, segment, and project the size of the Cognitive and Memory Enhancer Drugs market based on company, product type, application and key regions.

The global Cognitive and Memory Enhancer Drugs market is valued at 4056.6 million US$ in 2020 is expected to reach 5682.4 million US$ by the end of 2026, growing at a CAGR of 4.9% during 2021-2026.
This report focuses on Cognitive and Memory Enhancer Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Cognitive and Memory Enhancer Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Cognitive and Memory Enhancer Drugs market is segmented into
Aricept
Exelon
Namenda
Razadyne
Provigil
Ritalin
Adderall
Others

Segment by Application
Disease Treatment
Academic Performance
Athletic Performance
Others

Global Cognitive and Memory Enhancer Drugs Market: Regional Analysis
The Cognitive and Memory Enhancer Drugs market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Cognitive and Memory Enhancer Drugs market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Cognitive and Memory Enhancer Drugs Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Cognitive and Memory Enhancer Drugs market include:
Pfizer
Eisai Co
Allergan
Novartis
Takeda
Johnson & Johnson
Takeda Pharmaceutical Company Limited
AlternaScript
Cephalon
Ceretropic